Tus Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.91%

Tus Pharmaceutical Group Co Ltd (000590) has an Asset Resilience Ratio of 4.91% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥43.00 Million
≈ $6.29 Million USD Cash + Short-term Investments

Total Assets

CN¥875.56 Million
≈ $128.12 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2022)

This chart shows how Tus Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Check Tus Pharmaceutical Group Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tus Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tus Pharmaceutical Group Co Ltd (000590) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥43.00 Million 4.91%
Total Liquid Assets CN¥43.00 Million 4.91%

Asset Resilience Insights

  • Limited Liquidity: Tus Pharmaceutical Group Co Ltd maintains only 4.91% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Tus Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tus Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Tus Pharmaceutical Group Co Ltd (2002–2022)

The table below shows the annual Asset Resilience Ratio data for Tus Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 2.15% CN¥25.11 Million
≈ $3.67 Million
CN¥1.17 Billion
≈ $170.73 Million
-5.61pp
2021-12-31 7.76% CN¥75.15 Million
≈ $11.00 Million
CN¥967.83 Million
≈ $141.62 Million
-14.35pp
2017-12-31 22.12% CN¥193.23 Million
≈ $28.28 Million
CN¥873.74 Million
≈ $127.86 Million
+18.69pp
2014-12-31 3.42% CN¥20.09 Million
≈ $2.94 Million
CN¥586.82 Million
≈ $85.87 Million
+3.41pp
2006-12-31 0.02% CN¥85.15K
≈ $12.46K
CN¥545.36 Million
≈ $79.80 Million
+0.00pp
2005-12-31 0.01% CN¥93.07K
≈ $13.62K
CN¥664.58 Million
≈ $97.25 Million
0.00pp
2004-12-31 0.01% CN¥96.04K
≈ $14.05K
CN¥676.63 Million
≈ $99.01 Million
0.00pp
2003-12-31 0.02% CN¥130.61K
≈ $19.11K
CN¥685.16 Million
≈ $100.26 Million
-0.01pp
2002-12-31 0.02% CN¥180.63K
≈ $26.43K
CN¥724.86 Million
≈ $106.07 Million
--
pp = percentage points

About Tus Pharmaceutical Group Co Ltd

SHE:000590 China Drug Manufacturers - Specialty & Generic
Market Cap
$299.61 Million
CN¥2.05 Billion CNY
Market Cap Rank
#14780 Global
#4365 in China
Share Price
CN¥8.55
Change (1 day)
+3.89%
52-Week Range
CN¥7.71 - CN¥13.09
All Time High
CN¥26.17
About

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more